Cara Therapeutics Announces Presentations at Kidney Week 2019
Late-breaking oral presentation to highlight data from KALM-1 pivotal Phase 3 trial of KORSUVA™ Injection in hemodialysis patients with pruritus.
Read MoreSelect Page
Posted by Invest In Weed | Nov 1, 2019
Late-breaking oral presentation to highlight data from KALM-1 pivotal Phase 3 trial of KORSUVA™ Injection in hemodialysis patients with pruritus.
Read MorePosted by Invest In Weed | Oct 29, 2019
Study C-009 is designed to explore the effect of daily administration of OP0201 in patients with COME, a non-infectious form of otitis media.
Read MorePosted by Invest In Weed | Oct 28, 2019
Investors are recognizing that KALY’s technology is undervalued.
Read MorePosted by Invest In Weed | Oct 15, 2019
Liquid Gold Distillate: The New Cannabis Currency – is an amber-coloured purified distillate that can be worth more than the value of gold.
Read MorePosted by Invest In Weed | Oct 14, 2019
Patient enrollment increased approximately 20% to maintain >90% statistical power.
Read MoreGet stock alerts, news & related alerts straight to your inbox!